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Improvement of Memory by Means of Ultra-Low Doses of
Antibodies to S-100B Antigen
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Institute of Molecular Biology and Biophysics, Siberian Department of Russian Academy of Medical Sciences,
Novosibirsk, Russia
Antigen S-100B of nervous tissue, according to the data of numerous studies, affects the mechanisms of
nervous system plasticity and memory. The influence of ultralow doses of antibodies to S-100B
(6C dilution, according to the homeopathic pharmacopoeia) has been studied on three learning
behavioral models on Wistar rats, which were inhibitory avoidance, choosing of bowls with sucrose and
feeding behavior cessation after auditory signal. For all three tasks, parameters of reproduction of the
learned skills improved after per oral administration of potentiated antibodies to S-100B antigen
immediately after learning. Possible mechanisms of the anti-S-100B antibodies influence on memory
formation are discussed.
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Introduction
There is a constant interest in modern neuropharmacology and
medicine for analyzing physiological activity of low and ultralow
doses of drugs obtained by homeopathic methods (1–6). A clear
advantage of these drugs is absence of direct toxic effects that
makes possible their wide use. Preparations of antibodies to
neurospecific antigens are of high interest among such drugs, as
such antigens are involved in regulation of basic functions of the
nervous system. It also relates to the antigen S-100B of nervous
tissue that controls neuroglial relationship and, according to data
of numerous studies, affects mechanisms of plasticity of the
nervous system (7–15).
At the Institute of Molecular Biology and Biophysics, the
effects of antibodies to brain-specific antigen S-100 B on the
mechanisms of plasticity of the nervous system, including
the post-tetanic potentiation, have been studied for years (16).
A new stage began to analyze low concentrations of such
antibodies that often have an opposite effect to that of high
doses (3,4). The present workis a continuation of these studies.
The purpose of the work was to study the effects of ultralow
doses of anti-S-100B antibodies (preparation ‘Proprotene-100’)
on memory formation in rats. Three various types of tasks were
used as learning models: (i) inhibition of animal’s descent
from a safe platform onto an electrified grid, (ii) choosing a
bowl with sucrose solution and (iii) inhibition of feeding
behavior after auditory signal.
Methods
Antibodies
To prepare potentiated antibodies rabbit monospecific
multivalent serum to S-100B was used. Antibodies to S-100B
were isolated from the serum on columns with S-100B protein
immobilized on CNBr-sepharose (17,18). The immunoglobu-
lin solution was dialyzed against 0.15 M NaCl and concen-
trated using ultrafiltration. Antibodies did not affect liver,
lungs, kidney and other organs. Ultralow concentrations of the
antibody were obtained using routine homeopathic methods in
‘Materia Medica Holding’ company (Research and Production
Company, Moscow). The solution of antibodies (12 mg ml
 1)
was mixed with lactose in a ratio of 1:100 (0.05 ml of solution,
5 g of lactose) that made dilution C1. Dilution C2 was obtained
by adding 9.9 g lactose to 0.1 g C1. Distilled water was added
in a ratio of 1:99 (0.25 g/24.75 g). Then it was stirred no less
than 10 times to make the dilution C3. Dilution C4 was
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and then C6 were prepared using addition of distilled water
and mechanical stirring. Potentiated water was prepared using
water instead of antibody solution. 6C dilution (ratio 1:10
12)
was used in the experiments.
Rats
Experiments were performed on adult male Wistar rats
weighing 200–300 g from the animal house of the Novosibirsk
National Academy of Medical Sciences. Rats were kept in
pairs with a free access to water and food, under a 12 h
illumination per day. Solution of potentiated antibodies to S-
100B was administered to rats per os (0.5 ml) immediately
after three tasks learning sessions described above. During
learning to respond to auditory stimulus, solution was
additionally administered 24 and 1 h before training. Control
animals were given potentiated water (0.5 ml). During learning
to choose a bowl with sucrose, dexametasone was adminis-
tered per os to an additional comparison group in a dose of
0.3 mg kg
 1, which influence memory formation (19,20) due
to affecting amygdale, which is one of the key structures of
brain functioning (21,22).
Development and Testing of Inhibitory Avoidance
Training of inhibitory avoidance was carried out in a veneer
box of 50 · 25 · 25 cm. The floor in the testing chamber
consisted of parallel bronze bars with a diameter of 3 mm, the
distance between bars being 1 cm. On the left a 7 cm wide and
2.5 cm high wooden platform was located on which an animal
was delicately placed (23). During learning avoidance reac-
tion, the animal was descended from the platform, and when
all the four paws were on the grid, electric current was
automatically switched on (0.5 mA, 50 Hz, 2 s). The animals
were tested in 24 h time, with the electric current switched off.
Learning session was repeated in 4 weeks, conservation of the
inhibitory avoidance was tested in 24 h and in 7 days. Time of
the rat’s descent from the platform was recorded; maximal
duration of the test did not exceed 5 min.
Learning to Choose Sucrose Bowls
Experiments on choosing bowls with sucrose solution were
carried out in the testing chamber made of organic glass
(40 · 20 · 20 cm), and a floor made of metal plates. At each
side of the chamber 4 cm above the floor there were two
bowls, each 3 cm in diameter, the distance between the bowls
was 5 cm. The bowls contained 20% sucrose solution. The
animals were previously kept in the chamber for 10 min for
four consecutive days. Those with low consumption of
sucrose (<5% of exposition time) were excluded from the
experiment. During training session, the bowls on the left
were put under electric current of 0.15 mA, 50 Hz with a
latent period of 0.1 s. Learning sessions lasted 15 min and
were repeated in 2 days. In experiments numbers of animals’
contacts with the bowls separated by no less than 3 s
intervals were estimated.
Avoidance Reaction by Auditory Signal
Experiments were carried out in a chamber similar to those
described above, with bowls containing sucrose, and an
auditory signal. Animals were previously kept in the chamber
for 10 min for four consecutive days. Those with low
consumption of sucrose (<5% of exposition time) were
excluded from the experiment. During learning sessions, with
the beginning of animal’s consumption of sucrose solution the
following method was used: in 7 s time a sound of 800 Hz, 20
dB was switched on. Three seconds later all the bowls were
under electric current of 0.15 mA, 60 Hz. Combined action of
the stimuli lasted for 5 s. The session lasted 20 min and
included 10 auditory signals that animal could obtain. Testing
was made under switched-off current in 24 h and in 7 days.
Testing lasted 20 min. Estimated were latent periods of
cessation of drinking behavior after its start, completion of
drinking with sound signal and resuming of drinking behavior
after cessation of sound.
Stimulation and Registration of Reactions of
Rats Were Carried Out Automatically Using a
Computer
Statistics
Results were expressed as the mean ± SEM. Comparison of
data among three groups was performed using the one-way
analysis of variance (ANOVA) with Bonferroni’s post-test.
Comparison of data between two groups was performed by
Student’s test based on the variance of data examined by
F-test. When the P-value was <0.05, the difference was
considered to be significant.
Results
Ultralow Doses of Antibodies to S-100B and Inhibitory
Avoidance
In the experiment on development of inhibitory avoidance, the
latent period of descent from the platform in control and
experimental groups was about 4 s (see Table 1). When tested
in 24 h, the differences between the groups were not
significant. After 4 weeks the animals were trained repeatedly.
Testing of the reaction reproduction in 24 h indicated
significant increase of time of staying on the safe platform
(P < 0.05) of animals of the experimental group versus the
control group (by 44%). The next testing in 7 days showed a
conservation of the difference between experimental groups of
animals. The rats that were administered with antibodies
stayed on the platform 254 s on average, and those that were
given water stayed 144 s (P < 0.01).
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Reaction of Choosing Bowls with Sucrose Solution
Analysis of dynamics of learning to choose ‘safe’ bowl with
sucrose solution demonstrated that there were no considerable
differences in the number of contacts with bowls on the right
side (no punishment) between control and experimental,
experimental and dexamethasone groups, although in the
former two groups there was a strong tendency to increase the
number of such contacts from 10–11 to 19–20 as the training
went on, whereas in animals administered with dexamethasone
there were no changes (see Table 2).
Different dynamics were registered for bowls on the left
side with ‘punishment’ (see Table 3). As early as 3rd–4th
session (the data of each two consecutive trainings were
pooled), the rat group that were given dexamethasone
showed a significant decrease of numbers of contacts as
compared with the control (11.6 and 4.2), whereas in the group
that was given potentiated antibodies there was only a
tendency to 6.1. By the 5th–6th training sessions, the decrease
in number of contacts with bowls on the left side as compared
to the control was significant (P < 0.05) in the two
experimental groups (control, 9.7; antibodies, 4.7; dexametha-
sone, 4.0 contacts).
Ultralow Doses of Anti-S-100B Antibodies and
Avoidance Reaction to Auditory Signal
In the development of avoidance reaction to auditory signal,
the operational conditioning reflex developed after two or
three combinations, so that conditioned reactions appeared as
soon as after 10 exposures to the stimulus. The animals that
had been previously administered antibodies to S-100B
antigen showed a higher speed of learning than the control,
which was indicated as significant reduction of avoidance
latency (7.42 and 4.59 s, P < 0.05, see Fig. 1) and decrease of
time of consuming sucrose solution when exposed to auditory
stimulus (2.28 and 0.78 s, P < 0.01, see Fig. 2).
In 24 h after learning session, the avoidance latency
remained reduced in animals that had been administered with
antibodies as compared to the control (7.86 and 6.17 s,
P < 0.05, Fig. 1). Time of sucrose consumption on the
background of the auditory stimulus also decreased (3.27 and
1.37 s, P < 0.01, see Fig. 2).
Table 1. Latencies of rats‘ descent from the platform
Group of animals Control, n ¼ 14 Antibodies 6c, n ¼ 14
Learning
Learning 4.2 ± 1.1 4.1 ± 1.8
Test in 24 h 28.7 ± 10.4 49.2 ± 23.2
Repeated learning
Learning 40.5 ± 21.0 64.6 ± 29.4
Test in 24 h 188.2 ± 34.2 272.4 ± 19.4*
Test in 7 days 144.5 ± 25.9 254.4 ± 10.7**
*P < 0.05, **P< 0.01 versus control.
Table 2. Time courses of animals’ attempts to consume sucrose from the
right-hand drinking bowls
Groups of animals Control,
n ¼ 8
Antibodies,
n ¼ 8
Dexamethasone,
n ¼ 7
Prior to learning 11.75 ± 3.03 10.35 ± 2.49 12.71 ± 1.56
Sessions 1 þ 2 14.50 ± 3.13 11.50 ± 3.47 7.85 ± 1.94
Sessions 3 þ 4 14.62 ± 2.88 13.00 ± 4.45 8.42 ± 3.25
Sessions 5 þ 6 19.62 ± 5.45 19.75 ± 5.25 12.85 ± 3.40
Table 3. Time courses of animals’ attempts to consume sucrose from the
left-hand drinking bowls
Groups of animals Control,
n ¼ 8
Antibodies,
n ¼ 8
Dexamethasone,
n ¼ 7
Prior to learning 12.62 ± 3.11 10.75 ± 2.75 13.28 ± 1.68
Sessions 1 þ 2 12.37 ± 2.51 7.62 ± 1.64 7.14 ± 1.03
Sessions 3 þ 4 11.62 ± 2.40 6.12 ± 1.35 4.28 ± 1.84*
Sessions 5 þ 6 9.75 ± 1.94 4.75 ± 0.94* 4.00 ± 0.69*
*P< 0.05 versus control.
Figure 2. Behavioral characteristics during development of the avoidance
reaction to an acoustic stimulus: duration of sucrose consumption on
background of a sound stimulus (seconds). Note:* * P < 0.01 versus control.
There were 10 animals in each group.
Figure 1. Behavioral characteristics during development of the avoidance
reaction to an acoustic stimulus: latency of avoidance (seconds). Note:
*P < 0.05 versus control, **P < 0.01 versus control. There were 10 animals
in each group.
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avoidance latency control group had 8.62 s, experimental
group showed 6.05 s, P < 0.01; for sucrose consumption on the
background of sound signal control group showed 6.26 s, and
experimental group showed 1.40 s, P < 0.01 (Figs 1 and 2).
It is noteworthy that during the development of a
conditioned reflex, the acquisition of signal significance by
sound seems to have been accompanied by development of
conditioned reaction to time, which affected behavioral
parameters and resulted in manifestation of avoidance before
the effect of the auditory stimulus. Nevertheless, effects
associated with sound turned out to be the most demonstrative:
in the control group duration of sucrose consumption on the
background of sound signal increased from the first to the
second testing (P < 0.05), i.e. a decrease of conditioned
inhibition was shown. This may be characterized as a
manifestation of extinction in the control group and a higher
reflex stability in the experimental group that has not shown
such an increase (see Fig. 2).
Apart from the mentioned differences between groups of
animals related to avoidance latencies, in 24 h and in a week
after training, intervals of the resumption of sucrose solution
consumption increased in animals that had been administered
antibody preparations (49.97 and 128.09 s, P < 0.05; Fig. 3).
Discussion
The rats that were administered antibodies on the average
stayed on the platform longer than rats that were given water.
These results confirm better memorizing aversive stimulation
under the influence of low doses of antibodies to S-100B.
Administration of both dexamethasone and potentiated anti-
bodies improved the avoidance of ‘dangerous’ bowls. The
animals preliminarily administered antibodies to S-100B
antigen showed faster learning than the control group, which
was expressed in a significant reduction of avoidance latency
in the auditory task. The effects of conditioned stimulus
expressed as the rate of development and duration of
suppression of the feeding behavior were stronger in experi-
mental than in control animals.
Animals in the present study were exposed to three types of
learning tasks. First one required inhibition of motor activity,
the second required choosing one of two objects and the third
involved learning a skill to stop feeding behavior by auditory
signal. The tasks included processing of information obtained
through various sensory channels, proprioceptive, visual and
auditory. In all three cases, administration of potentiated
antibodies to S-100B improved learning skills and facilitated
long-term and short-term (working) memory formation in the
task of avoiding of auditory signal.
When discussing possible mechanisms of effects of poten-
tiated antibodies on memory, it is expedient to remember that
the amount of S-100B protein in the brain increases during
learning and the anti-S-100 antibodies in usual doses disturb
the processes of memory consolidation (11,24). The influence
of S-100B on memory seems to be associated with the
regulation of transcription process by these proteins (12,14).
Therefore, the effect of S-100B is associated with memory
improvement.
The effect of antibodies to S-100B in ultralow doses may be
directly opposite to that of usual doses of antibodies, therefore
improving the learned skills reproduction (25). It was
demonstrated in the present work as well that Anti-S-100
antibodies in usual doses changed the frequency of action
potential generation in spontaneously active neurons and
blocked formation of long-term potentiation (model of
memory) in mossy fiber synapses, but 20 min pre-incubation
of snail ganglia or hippocampal slices with ultralow dose (6C)
anti-S-100 abolished the effects of the same antibodies in high
concentrations (3).
The following explanations of this situation are possible.
First, usual doses of antibodies decrease the functional activity
of S-100B antigen molecules, inhibits the electrical activity of
neurons (26) and the stimulation of adenylate cyclase (27),
whereas its ultralow doses enhance the functional activity of
the protein, e.g. by changing of S-100B binding with neuron
and glial membranes (16). Second, low doses of antibodies via
regulatory mechanisms enhance the release of S-100B
molecules from glial cells, changing membrane electric
potential. There are receptors of 5-HT on glial cells.
Stimulation of these receptors enhanced the release of S-
100B from these cells (9,28). It may be regarded as one of the
mechanisms of modulation memory via serotonergic system
(29). Ultralow doses of anti-S-100B antibodies probably may
affect in similar way, enhancing the release of S-100B. All this
ultimately can result in a more efficient influence of S-100B on
the transcription of genes (12,14) involved, as it is believed, in
the memory trace formation.
The effect of ultralow doses of antibodies to S-100B on the
mechanisms of brain plasticity is determined presumably by
their interaction to the antigen on the outer surface of neuronal
membranes and glial cells, by influencing its release via glial
cells or penetration into neurons. Finally, the ultralow doses of
anti-S-100B may directly affect autoantibodies (3), possibly
involving physical–chemical properties and structure of water
solution (30). Memory disorders in psychiatric patients are
Figure 3. Behavioral characteristics during development of the avoidance
reaction to an acoustic stimulus: renewal of drinking behavior in seconds.
*P < 0.05. Note:* P < 0.05 versus control. There were 10 animals in each
group.
544 Effects of Anti-S-100 on learningcharacterized by high levels of autoantibodies to S-100 protein
(31,32). Thus, yet another possibility of getting control over
memory mechanisms of men and animals is shown. At present,
the authors of the paper are in the process of studying the
influence of ultralow doses of antibodies to S-100B in the
experiments on animals with learning and memory disorders,
e.g. rats genetically predisposed to catalepsy (33).
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